摘要 |
<p>The present invention comprises monoclonal antibodies reactive with native C-reactive protein (CRP) and modified CRP having the specificities described herein. The invention also comprises the hybridomas used to produce these antibodies. Monoclonal antibody 3H12 is used to show inhibition binding and a lack of inhibition binding by use of peptides. The claimed antibodies may be used to detect or quantitate native CRP and modified CRP, and kits for performing such assays are part of the invention.</p> |